{"DataElement":{"publicId":"7799625","version":"1","preferredName":"Immune Checkpoint Inhibitor Therapeutic Procedure Disease Progression Pattern Stratification Factors Type","preferredDefinition":"A response used to identifiable the pattern disease progression in a therapeutic agent that inhibits any of the immune checkpoint inhibitory proteins.","longName":"7799621v1.0:7799622v1.0","context":"ECOG-ACRIN","contextVersion":"1","DataElementConcept":{"publicId":"7799621","version":"1","preferredName":"Immune Checkpoint Inhibitor Therapeutic Procedure Disease Progression Pattern Stratification Factors","preferredDefinition":"An agent that inhibits any of the immune checkpoint inhibitory proteins._An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process._A process that manifests as the worsening of a disease over time._An arrangement of objects, facts, behaviors, or other things which have scientific, mathematical, geometric, statistical, or other meaning._Selected pre-treatment factors by which patients are segregated to assure equal balance of these factors before randomization to the intervention arms of a clinical protocol.","longName":"7799619v1.0:5544737v1.0","context":"ECOG-ACRIN","contextVersion":"1","ObjectClass":{"publicId":"7799619","version":"1","preferredName":"Immune Checkpoint Inhibitor Therapeutic Procedure Disease Progression Pattern","preferredDefinition":"An agent that inhibits any of the immune checkpoint inhibitory proteins.:An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.:A process that manifests as the worsening of a disease over time.:An arrangement of objects, facts, behaviors, or other things which have scientific, mathematical, geometric, statistical, or other meaning.","longName":"C143250:C49236:C17747:C25336","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immune Checkpoint Inhibitor","conceptCode":"C143250","definition":"An agent that inhibits any of the immune checkpoint inhibitory proteins.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Disease Progression","conceptCode":"C17747","definition":"A process that manifests as the worsening of a disease over time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Pattern","conceptCode":"C25336","definition":"An arrangement of objects, facts, behaviors, or other things which have scientific, mathematical, geometric, statistical, or other meaning.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CEF379DA-329A-4999-E053-4EBD850AF682","latestVersionIndicator":"Yes","beginDate":"2021-10-22","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2021-10-22","modifiedBy":"ONEDATA","dateModified":"2021-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"5544737","version":"1","preferredName":"Stratification Factors","preferredDefinition":"Selected pre-treatment factors by which patients are segregated to assure equal balance of these factors before randomization to the intervention arms of a clinical protocol.","longName":"C16153","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stratification Factors","conceptCode":"C16153","definition":"Selected pre-treatment factors by which patients are segregated to assure equal balance of these factors before randomization to the intervention arms of a clinical protocol.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3FD8CA83-7B2E-5DA4-E053-F662850AFE65","latestVersionIndicator":"Yes","beginDate":"2016-10-27","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2016-10-27","modifiedBy":"ONEDATA","dateModified":"2016-10-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CEF379DA-32A8-4999-E053-4EBD850AF682","latestVersionIndicator":"Yes","beginDate":"2021-10-22","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2021-10-22","modifiedBy":"GARRIDOJ","dateModified":"2022-01-10","changeDescription":"Created for EA3202, 10/22/2021 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7799622","version":"1","preferredName":"ICI Progression Pattern Type","preferredDefinition":"Something distinguishable as an identifiable class based on common qualities.","longName":"7799622v1.0","context":"ECOG-ACRIN","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"After discontinuing ICI","valueDescription":"Post Discontinue Immune Checkpoint Inhibitor","ValueMeaning":{"publicId":"7799623","version":"1","preferredName":"Post Discontinue Immune Checkpoint Inhibitor","longName":"7799623","preferredDefinition":"Happening at a time subsequent to a reference time; later in time or order.: To stop or end, permanently or temporarily.: An agent that inhibits any of the immune checkpoint inhibitory proteins.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Post","conceptCode":"C38008","definition":"Happening at a time subsequent to a reference time; later in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Discontinue","conceptCode":"C25484","definition":"To stop or end, permanently or temporarily.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Immune Checkpoint Inhibitor","conceptCode":"C143250","definition":"An agent that inhibits any of the immune checkpoint inhibitory proteins.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CEF38ADD-5670-3EC5-E053-4EBD850A5D4A","latestVersionIndicator":"Yes","beginDate":"2021-10-22","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2021-10-22","modifiedBy":"ONEDATA","dateModified":"2021-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CEF38ADD-5689-3EC5-E053-4EBD850A5D4A","beginDate":"2021-10-22","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2021-10-22","modifiedBy":"ONEDATA","dateModified":"2021-10-22","deletedIndicator":"No"},{"value":"While on ICI","valueDescription":"Upon Immune Checkpoint Inhibitor","ValueMeaning":{"publicId":"7799624","version":"1","preferredName":"Upon Immune Checkpoint Inhibitor","longName":"7799624","preferredDefinition":"Used to indicate that an event is to immediately follow another event.: An agent that inhibits any of the immune checkpoint inhibitory proteins.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Upon","conceptCode":"C65137","definition":"Used to indicate that an event is to immediately follow another event.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Immune Checkpoint Inhibitor","conceptCode":"C143250","definition":"An agent that inhibits any of the immune checkpoint inhibitory proteins.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CEF38ADD-5696-3EC5-E053-4EBD850A5D4A","latestVersionIndicator":"Yes","beginDate":"2021-10-22","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2021-10-22","modifiedBy":"ONEDATA","dateModified":"2021-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CEF38ADD-56AF-3EC5-E053-4EBD850A5D4A","beginDate":"2021-10-22","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2021-10-22","modifiedBy":"ONEDATA","dateModified":"2021-10-22","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CEF38ADD-5655-3EC5-E053-4EBD850A5D4A","latestVersionIndicator":"Yes","beginDate":"2021-10-22","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2021-10-22","modifiedBy":"GARRIDOJ","dateModified":"2022-01-10","changeDescription":"Created for EA3202, 10/22/2021 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3314482","version":"1","longName":"Type of Category","context":"ECOG-ACRIN","ClassificationSchemeItems":[{"publicId":"5936696","version":"1","longName":"Disease Assessment ","context":"ECOG-ACRIN"},{"publicId":"6013685","version":"1","longName":"Stratification Factor","context":"ECOG-ACRIN"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Disease progression pattern o","type":"Preferred Question Text","description":"Disease progression pattern on first-line ICI","url":null,"context":"ECOG-ACRIN"}],"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CEF3A2A8-62B9-7216-E053-4EBD850AECAB","latestVersionIndicator":"Yes","beginDate":"2021-10-22","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2021-10-22","modifiedBy":"GARRIDOJ","dateModified":"2022-01-10","changeDescription":"Created for EA3202, 10.22.2021 (JG)","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}